1 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 10 of 430 | 4330 prescriptions Less than 1% of all prescriptions | 3850 | 920 patients 19% of all patients | 810 patients 16% of all patients | |
2 VENTOLIN HFA (ALBUTEROL SULFATE) | 10 of 3190 | 4000 prescriptions Less than 1% of all prescriptions | 3410 | 1820 patients 37% of all patients | 1570 patients 32% of all patients | |
3 SPIRIVA (TIOTROPIUM BROMIDE) | 20 of 870 | 2300 prescriptions Less than 1% of all prescriptions | 2010 | 490 patients 10% of all patients | < 11 | |
4 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 20 of 1800 | 2030 prescriptions Less than 1% of all prescriptions | 1770 | 520 patients 11% of all patients | < 11 | |
5 FLUTICASONE-SALMETEROL (FLUTICASONE PROPION/SALMETEROL) | 10 of 120 | 2160 prescriptions Less than 1% of all prescriptions | 2160 | 520 patients 11% of all patients | 520 patients 11% of all patients | |
6 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 30 of 370 | 1900 prescriptions Less than 1% of all prescriptions | 1460 | 360 patients 7% of all patients | < 11 | |
7 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 30 of 1150 | 2070 prescriptions Less than 1% of all prescriptions | 1690 | 630 patients 13% of all patients | 510 patients 10% of all patients | |
8 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 10 of 210 | 1590 prescriptions Less than 1% of all prescriptions | | 410 patients 8% of all patients | < 11 | |
9 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 20 of 210 | 1500 prescriptions Less than 1% of all prescriptions | 1350 | 270 patients 5% of all patients | < 11 | |
10 FLUTICASONE PROPIONATE | 30 of 3830 | 1360 prescriptions Less than 1% of all prescriptions | 1250 | 530 patients 11% of all patients | < 11 | |
11 PREDNISONE | 60 of 6690 | 1750 prescriptions Less than 1% of all prescriptions | 1530 | 980 patients 20% of all patients | 820 patients 17% of all patients | |
12 ARNUITY ELLIPTA (FLUTICASONE FUROATE) | 10 of 50 | 810 prescriptions Less than 1% of all prescriptions | 700 | 290 patients 6% of all patients | < 11 | |
13 MONTELUKAST SODIUM | 90 of 1810 | 670 prescriptions Less than 1% of all prescriptions | | 150 patients 3% of all patients | < 11 | |
14 AZITHROMYCIN | 70 of 3210 | 750 prescriptions Less than 1% of all prescriptions | | 220 patients 4% of all patients | < 11 | A |
15 FLOVENT HFA (FLUTICASONE PROPIONATE) | 10 of 640 | 680 prescriptions Less than 1% of all prescriptions | | 210 patients 4% of all patients | < 11 | |
16 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 20 of 510 | 470 prescriptions Less than 1% of all prescriptions | 470 | 110 patients 2% of all patients | 110 patients 2% of all patients | |
17 OMEPRAZOLE | 1440 of 4980 | 300 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
18 PROAIR HFA (ALBUTEROL SULFATE) | 170 of 1950 | 440 prescriptions Less than 1% of all prescriptions | | 250 patients 5% of all patients | < 11 | |
19 PULMICORT FLEXHALER (BUDESONIDE) | 10 of 80 | 210 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 40 of 40 | 190 prescriptions Less than 1% of all prescriptions | 190 | < 11 | < 11 | |
21 QVAR REDIHALER (BECLOMETHASONE DIPROPIONATE) | 10 of 20 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
22 DULERA (MOMETASONE/FORMOTEROL) | 20 of 90 | 180 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | |
23 DOXYCYCLINE MONOHYDRATE | 120 of 2140 | 500 prescriptions Less than 1% of all prescriptions | | 460 patients 9% of all patients | < 11 | A |
24 DALIRESP (ROFLUMILAST) | 60 of 100 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
25 BEVESPI AEROSPHERE (GLYCOPYRROLATE/FORMOTEROL FUM) | 10 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
26 XOPENEX HFA (LEVALBUTEROL TARTRATE) | 10 of 20 | 180 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | |
27 AMOXICILLIN-CLAVULANATE POTASS (AMOXICILLIN/POTASSIUM CLAV) | 360 of 2850 | 120 prescriptions Less than 1% of all prescriptions | | 120 patients 2% of all patients | < 11 | A |